Prognosis
Prognosis is the expected course and outcome of a disease based on clinical evidence. For mesothelioma, prognosis depends on the cancer stage at diagnosis, cell type, patient age and overall health, and treatment response. The overall median survival is 12–21 months, though individual outcomes vary significantly.
Several key factors influence mesothelioma prognosis. Epithelioid cell type carries the best outlook, with median survival of 14–19 months, while sarcomatoid has the poorest at 4–12 months. Early-stage diagnosis (stages I–II) significantly improves survival compared to advanced disease, and younger patients with good performance status tend to respond better to treatment.
Prognosis has improved in recent years with the FDA approval of immunotherapy (nivolumab plus ipilimumab) and advances in surgical techniques. Peritoneal mesothelioma patients treated with cytoreductive surgery and HIPEC have seen particularly notable improvements, with some studies reporting median survival exceeding four years.
Patients should discuss their individual prognosis with a mesothelioma specialist who can account for all relevant factors. Statistics represent population averages and may not reflect an individual patient's situation. Explore treatment options and consider clinical trials for emerging therapies.
- Also known as
- Outlook, Survival outlook
- Category
- Medical
- Related terms
- Cancer Staging, Epithelioid Mesothelioma, Sarcomatoid Mesothelioma, Mesothelioma, Immunotherapy
What is the average life expectancy for mesothelioma?
The overall median survival for mesothelioma is 12 to 21 months. However, outcomes vary significantly based on stage, cell type, age, and treatment response.
Which type of mesothelioma has the best prognosis?
Peritoneal mesothelioma with epithelioid cell type treated with surgery and HIPEC has the best prognosis, with some studies reporting median survival exceeding four years.
Have questions about Prognosis? Our attorneys can explain how this applies to your situation — at no cost.